Sustained reduction of alloantibody secreting plasma cells and donor specific antibody with proteasome inhibition in mice

Within a murine model, proteasome inhibition can eliminate alloantibody secreting plasma cells, and reduce alloantibody. Cessation of bortezomib is not associated with return of DSA.